Rheumatoid arthritis: Treatment evolution over the years
<p>Rheumatoid arthritis (RA) is a systemic, inflammatory autoimmune disorder affecting approximately 0.5-1% [1] of the general population. It is characterized by inflammation and proliferation of the synovial lining, leading to destructive changes within the synovial-lined joints [2], especial...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Book |
| Published: |
Open Journal of Pharmacology and Pharmacotherapeutics - Peertechz Publications,
2020-05-16.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000 am a22000003u 4500 | ||
|---|---|---|---|
| 001 | peertech__10_17352_ojpp_000013 | ||
| 042 | |a dc | ||
| 100 | 1 | 0 | |a Eleftherios Pelechas |e author |
| 700 | 1 | 0 | |a Panagiota Karagianni |e author |
| 245 | 0 | 0 | |a Rheumatoid arthritis: Treatment evolution over the years |
| 260 | |b Open Journal of Pharmacology and Pharmacotherapeutics - Peertechz Publications, |c 2020-05-16. | ||
| 520 | |a <p>Rheumatoid arthritis (RA) is a systemic, inflammatory autoimmune disorder affecting approximately 0.5-1% [1] of the general population. It is characterized by inflammation and proliferation of the synovial lining, leading to destructive changes within the synovial-lined joints [2], especially if left untreated. Patients suffering from RA, usually complain about pain and swelling of the affected joints as well as morning stiffness in and around the joints, lasting at least 1 hour before maximal improvement [3].</p> | ||
| 540 | |a Copyright © Eleftherios Pelechas et al. | ||
| 546 | |a en | ||
| 655 | 7 | |a Review Article |2 local | |
| 856 | 4 | 1 | |u https://doi.org/10.17352/ojpp.000013 |z Connect to this object online. |